71 related articles for article (PubMed ID: 27701879)
1. Correlating symptoms and their changes with survival in patients with brain metastases.
Wong E; Rowbottom L; Tsao M; Zhang L; McDonald R; Danjoux C; Barnes E; Chan S; Chow E
Ann Palliat Med; 2016 Oct; 5(4):253-266. PubMed ID: 27701879
[TBL] [Abstract][Full Text] [Related]
2. Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy.
Wong J; Hird A; Zhang L; Tsao M; Sinclair E; Barnes E; Danjoux C; Chow E
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1125-31. PubMed ID: 19231099
[TBL] [Abstract][Full Text] [Related]
3. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
4. Could time of whole brain radiotherapy delivery impact overall survival in patients with multiple brain metastases?
Chan S; Rowbottom L; McDonald R; Zhang L; Bjarnason GA; Tsao M; Danjoux C; Barnes E; Lam H; Popovic M; DeAngelis C; Chow E
Ann Palliat Med; 2016 Oct; 5(4):267-279. PubMed ID: 27806623
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
[TBL] [Abstract][Full Text] [Related]
6. Symptoms and quality of life in patients with brain metastases receiving whole-brain radiation therapy.
Wong E; Zhang L; Rowbottom L; Chiu N; Chiu L; McDonald R; Tsao M; Barnes E; Danjoux C; Chow E
Support Care Cancer; 2016 Nov; 24(11):4747-59. PubMed ID: 27358169
[TBL] [Abstract][Full Text] [Related]
7. Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases.
Chow E; Davis L; Holden L; Tsao M; Danjoux C
J Pain Symptom Manage; 2005 Jul; 30(1):18-23. PubMed ID: 16043003
[TBL] [Abstract][Full Text] [Related]
8. Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma.
Claude L; Perol D; Ray-Coquard I; Petit T; Blay JY; Carrie C; Bachelot T
Radiother Oncol; 2005 Sep; 76(3):334-9. PubMed ID: 16024123
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases.
Steinmann D; Paelecke-Habermann Y; Geinitz H; Aschoff R; Bayerl A; Bölling T; Bosch E; Bruns F; Eichenseder-Seiss U; Gerstein J; Gharbi N; Hagg J; Hipp M; Kleff I; Müller A; Schäfer C; Schleicher U; Sehlen S; Theodorou M; Wypior HJ; Zehentmayr F; van Oorschot B; Vordermark D
BMC Cancer; 2012 Jul; 12():283. PubMed ID: 22780988
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases.
Jung TY; Chung WK; Oh IJ
Clin Neurol Neurosurg; 2014 Apr; 119():80-3. PubMed ID: 24635931
[TBL] [Abstract][Full Text] [Related]
11. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
Rades D; Dunst J; Schild SE
Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
[TBL] [Abstract][Full Text] [Related]
12. Symptom clusters in cancer patients with brain metastases.
Chow E; Fan G; Hadi S; Wong J; Kirou-Mauro A; Filipczak L
Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):76-82. PubMed ID: 17981447
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
14. Gamma Knife surgery for the treatment of 5 to 15 metastases to the brain: clinical article.
Salvetti DJ; Nagaraja TG; McNeill IT; Xu Z; Sheehan J
J Neurosurg; 2013 Jun; 118(6):1250-7. PubMed ID: 23540265
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of the palliative effect of whole-brain radiotherapy in patients with brain metastases and poor performance status.
Komosinska K; Kepka L; Niwinska A; Pietrzak L; Wierzchowski M; Tyc-Szczepaniak D; Kaczmarczyk A; Bujko K
Acta Oncol; 2010 Apr; 49(3):382-8. PubMed ID: 20397770
[TBL] [Abstract][Full Text] [Related]
16. Gamma knife surgery for brain metastases: indications for and limitations of a local treatment protocol.
Serizawa T; Saeki N; Higuchi Y; Ono J; Iuchi T; Nagano O; Yamaura A
Acta Neurochir (Wien); 2005 Jul; 147(7):721-6; discussion 726. PubMed ID: 15891808
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.
Aoyama H; Tago M; Shirato H;
JAMA Oncol; 2015 Jul; 1(4):457-64. PubMed ID: 26181254
[TBL] [Abstract][Full Text] [Related]
19. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
Nieder C; Andratschke N; Grosu AL; Molls M
Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
[TBL] [Abstract][Full Text] [Related]
20. Predicted survival in patients with brain metastases from colorectal cancer: Is a current nomogram helpful?
Nieder C; Hintz M; Grosu AL
Clin Neurol Neurosurg; 2016 Apr; 143():107-10. PubMed ID: 26914143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
